3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Burkitt Lymphoma
13
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma, Large B-Cell, Diffuse
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Prostatic Neoplasms
2
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
Leukemia, Biphenotypic, Acute
2
Plasmablastic Lymphoma
1
Multiple Myeloma
1
Melanoma
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
HTLV-I Infections
1
Down Syndrome
1
Carcinoma, Merkel Cell
1
Carcinoma, Basal Cell
1
Ann Arbor Stage II Mantle Cell Lymphoma
1
Interventions
fludarabine phosphate
3
Whole-Body Irradiation
3
Methotrexate
3
Cyclophosphamide
3
ponatinib
2
merphos
2
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Melphalan
2
Busulfan
2
venetoclax
1
blinatumomab
1
Thiotepa
1
Sirolimus
1
Rituximab
1
N,N-dicyclohexyl-isoborneol-10-sulfonamide
1
Injections
1
Etoposide
1
Decitabine
1
Cytarabine
1
Cyclosporine
1
Cord Blood Stem Cell Transplantation
1
Clofarabine
1
CT-P10
1
Antilymphocyte Serum
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myeloid, Accelerated Phase
×
deltacortene
×
30 days
×
Clear all
No trials found.